Skip to content

Effect of Pressure Pump for Evaluation of Lymphedema to suggest Individualized Treatment Method in Breast Cancer Patients

Effect of Pressure Pump for Evaluation of Lymphedema to suggest Individualized Treatment Method in Breast Cancer Patients

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CRIS
Registry ID
KCT0005792
Enrollment
50
Registered
2021-01-19
Start date
2021-01-18
Completion date
Unknown
Last updated
2021-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : During the lymphoscintigraphy test, 30 minutes after radioisotope injection, cuffs will be worn on both upper extremities, and pressure pumps (UAM-12000NB) will be operated to sequent

Sponsors

Seoul National University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Breast cancer patients who visited for lymphedema treatment 2. Those who can read and fill out questionnaires 3. Adult men and women over 20 years old 4. Those who agreed to participate in the study and follow-up observation

Exclusion criteria

Exclusion criteria: 1. Patients with poor general condition so that it is difficult to perform the test 2. People with serious psychiatric problems 3. Employees or students within the research institute that are judged to be difficult to voluntarily participate 4. Others In addition to the above items, if the clinical trial researcher is judged to be inadequate or difficult to respond to the survey

Design outcomes

Primary

MeasureTime frame
The number of successfully treated patients (volume reduction by more than 15%) in the experimental group and the control group according to the imaging finding

Secondary

MeasureTime frame
Average volume reduction rate after treatment compared to baseline in the experimental group;Comparison of average of edema reduction according to other imaging findings;QOL score using EORTC after treatment against baseline

Countries

Korea, Republic of

Contacts

Public Contactjimin lee

Seoul National University Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026